Drug General Information
Drug ID	D0A5ZJ
Former ID	DIB008755
Drug Name	DW-1350
Synonyms	DW-1352; Osteoblast modulator (oral, osteoporosis), Dong Wha/ Teijin/ Procter & Gamble
Drug Type	Small molecular drug
Indication	Osteoporosis [ICD9: 733.0, V07.4; ICD10:M80-M81, Z79.890]		Terminated	[548554]
Company	Dong Wha Pharmaceutical Co Ltd
Structure		Download 2D MOL 3D MOL
Formula	C25H31N3O3S
Canonical SMILES	c1(sc(nc1c1ccc(OCCCCCOc2ccc(cc2)/C(=N\O)/N)cc1)C)C(C)C
CAS Number	CAS 491577-61-8
PubChem Compound ID	10139005
Target and Pathway
Target(s)	Leukotriene B4 receptor 1	Target Info	Modulator	[548594]
KEGG Pathway	Neuroactive ligand-receptor interaction
NetPath Pathway	IL4 Signaling Pathway
Reactome	Leukotriene receptors
	G alpha (q) signalling events
WikiPathways	Nucleotide GPCRs
	GPCRs, Class A Rhodopsin-like
	Gastrin-CREB signalling pathway via PKC and MAPK
	Spinal Cord Injury
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 548554	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026567)
Ref 548594	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026850)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.